Range Of Motion Physical Therapy, P.a. | |
4 Cornwall Dr, Suite 220, East Brunswick, NJ 08816-3332 | |
(732) 257-0900 | |
(732) 257-5099 |
Full Name | Range Of Motion Physical Therapy, P.a. |
---|---|
Type | Facility |
Speciality | Physical Therapist |
Location | 4 Cornwall Dr, East Brunswick, New Jersey |
Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053523084 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 40QA01658800 (New Jersey) | Primary |
Provider Name | Maricel C Lazo |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1033368279 PECOS PAC ID: 8527964139 Enrollment ID: I20031212000071 |
News Archive
Forthcoming in Physiological and Biochemical Zoology, a fascinating new selection of papers collects leading experimental research in evolution and artificial selection, providing insight into how organisms adapt to changing environmental conditions and fluctuations.
In 1960, scientists described the "Philadelphia chromosome" that causes chronic myeloid leukemia, and in 2001 the Food and Drug Administration approved the drug imatinib to disable the action of this cancer-causing genetic change.
Many people get on with their lives after traumatic experiences without any psychological suffering. This is because, in spite of all the trauma, they manage to pigeonhole what they have experienced. Although this sense of coherence was first described in the 1970s, measuring it has remained problematic to this day.
SYGNIS AG, the Group which includes Expedeon Holdings, Expedeon, and C.B.S. Scientific Company, today announced the launch of its TruePrime apoptotic cell free DNA amplification kit, under the Expedeon brand.
› Verified 4 days ago
Provider Name | Ra Anan Levy |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1871603761 PECOS PAC ID: 6002890175 Enrollment ID: I20040616000314 |
News Archive
Forthcoming in Physiological and Biochemical Zoology, a fascinating new selection of papers collects leading experimental research in evolution and artificial selection, providing insight into how organisms adapt to changing environmental conditions and fluctuations.
In 1960, scientists described the "Philadelphia chromosome" that causes chronic myeloid leukemia, and in 2001 the Food and Drug Administration approved the drug imatinib to disable the action of this cancer-causing genetic change.
Many people get on with their lives after traumatic experiences without any psychological suffering. This is because, in spite of all the trauma, they manage to pigeonhole what they have experienced. Although this sense of coherence was first described in the 1970s, measuring it has remained problematic to this day.
SYGNIS AG, the Group which includes Expedeon Holdings, Expedeon, and C.B.S. Scientific Company, today announced the launch of its TruePrime apoptotic cell free DNA amplification kit, under the Expedeon brand.
› Verified 4 days ago
Provider Name | Karen J. Gala |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1174735104 PECOS PAC ID: 7315106481 Enrollment ID: I20120308000531 |
News Archive
Forthcoming in Physiological and Biochemical Zoology, a fascinating new selection of papers collects leading experimental research in evolution and artificial selection, providing insight into how organisms adapt to changing environmental conditions and fluctuations.
In 1960, scientists described the "Philadelphia chromosome" that causes chronic myeloid leukemia, and in 2001 the Food and Drug Administration approved the drug imatinib to disable the action of this cancer-causing genetic change.
Many people get on with their lives after traumatic experiences without any psychological suffering. This is because, in spite of all the trauma, they manage to pigeonhole what they have experienced. Although this sense of coherence was first described in the 1970s, measuring it has remained problematic to this day.
SYGNIS AG, the Group which includes Expedeon Holdings, Expedeon, and C.B.S. Scientific Company, today announced the launch of its TruePrime apoptotic cell free DNA amplification kit, under the Expedeon brand.
› Verified 4 days ago
Provider Name | Bina Parikh |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1215201306 PECOS PAC ID: 6103087820 Enrollment ID: I20120405000282 |
News Archive
Forthcoming in Physiological and Biochemical Zoology, a fascinating new selection of papers collects leading experimental research in evolution and artificial selection, providing insight into how organisms adapt to changing environmental conditions and fluctuations.
In 1960, scientists described the "Philadelphia chromosome" that causes chronic myeloid leukemia, and in 2001 the Food and Drug Administration approved the drug imatinib to disable the action of this cancer-causing genetic change.
Many people get on with their lives after traumatic experiences without any psychological suffering. This is because, in spite of all the trauma, they manage to pigeonhole what they have experienced. Although this sense of coherence was first described in the 1970s, measuring it has remained problematic to this day.
SYGNIS AG, the Group which includes Expedeon Holdings, Expedeon, and C.B.S. Scientific Company, today announced the launch of its TruePrime apoptotic cell free DNA amplification kit, under the Expedeon brand.
› Verified 4 days ago
Provider Name | Arturo Villanueva |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1689921132 PECOS PAC ID: 4183943962 Enrollment ID: I20150428002159 |
News Archive
Forthcoming in Physiological and Biochemical Zoology, a fascinating new selection of papers collects leading experimental research in evolution and artificial selection, providing insight into how organisms adapt to changing environmental conditions and fluctuations.
In 1960, scientists described the "Philadelphia chromosome" that causes chronic myeloid leukemia, and in 2001 the Food and Drug Administration approved the drug imatinib to disable the action of this cancer-causing genetic change.
Many people get on with their lives after traumatic experiences without any psychological suffering. This is because, in spite of all the trauma, they manage to pigeonhole what they have experienced. Although this sense of coherence was first described in the 1970s, measuring it has remained problematic to this day.
SYGNIS AG, the Group which includes Expedeon Holdings, Expedeon, and C.B.S. Scientific Company, today announced the launch of its TruePrime apoptotic cell free DNA amplification kit, under the Expedeon brand.
› Verified 4 days ago
Provider Name | Pooja Patel |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1851613350 PECOS PAC ID: 5395055776 Enrollment ID: I20151116000856 |
News Archive
Forthcoming in Physiological and Biochemical Zoology, a fascinating new selection of papers collects leading experimental research in evolution and artificial selection, providing insight into how organisms adapt to changing environmental conditions and fluctuations.
In 1960, scientists described the "Philadelphia chromosome" that causes chronic myeloid leukemia, and in 2001 the Food and Drug Administration approved the drug imatinib to disable the action of this cancer-causing genetic change.
Many people get on with their lives after traumatic experiences without any psychological suffering. This is because, in spite of all the trauma, they manage to pigeonhole what they have experienced. Although this sense of coherence was first described in the 1970s, measuring it has remained problematic to this day.
SYGNIS AG, the Group which includes Expedeon Holdings, Expedeon, and C.B.S. Scientific Company, today announced the launch of its TruePrime apoptotic cell free DNA amplification kit, under the Expedeon brand.
› Verified 4 days ago
Provider Name | Sean W Waters |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1528157385 PECOS PAC ID: 4284679176 Enrollment ID: I20160920000830 |
News Archive
Forthcoming in Physiological and Biochemical Zoology, a fascinating new selection of papers collects leading experimental research in evolution and artificial selection, providing insight into how organisms adapt to changing environmental conditions and fluctuations.
In 1960, scientists described the "Philadelphia chromosome" that causes chronic myeloid leukemia, and in 2001 the Food and Drug Administration approved the drug imatinib to disable the action of this cancer-causing genetic change.
Many people get on with their lives after traumatic experiences without any psychological suffering. This is because, in spite of all the trauma, they manage to pigeonhole what they have experienced. Although this sense of coherence was first described in the 1970s, measuring it has remained problematic to this day.
SYGNIS AG, the Group which includes Expedeon Holdings, Expedeon, and C.B.S. Scientific Company, today announced the launch of its TruePrime apoptotic cell free DNA amplification kit, under the Expedeon brand.
› Verified 4 days ago
Provider Name | Pooja Shah |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1386038743 PECOS PAC ID: 0143517789 Enrollment ID: I20160924000059 |
News Archive
Forthcoming in Physiological and Biochemical Zoology, a fascinating new selection of papers collects leading experimental research in evolution and artificial selection, providing insight into how organisms adapt to changing environmental conditions and fluctuations.
In 1960, scientists described the "Philadelphia chromosome" that causes chronic myeloid leukemia, and in 2001 the Food and Drug Administration approved the drug imatinib to disable the action of this cancer-causing genetic change.
Many people get on with their lives after traumatic experiences without any psychological suffering. This is because, in spite of all the trauma, they manage to pigeonhole what they have experienced. Although this sense of coherence was first described in the 1970s, measuring it has remained problematic to this day.
SYGNIS AG, the Group which includes Expedeon Holdings, Expedeon, and C.B.S. Scientific Company, today announced the launch of its TruePrime apoptotic cell free DNA amplification kit, under the Expedeon brand.
› Verified 4 days ago
Provider Name | Urviben Tewar |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1295265817 PECOS PAC ID: 6608106851 Enrollment ID: I20191001002314 |
News Archive
Forthcoming in Physiological and Biochemical Zoology, a fascinating new selection of papers collects leading experimental research in evolution and artificial selection, providing insight into how organisms adapt to changing environmental conditions and fluctuations.
In 1960, scientists described the "Philadelphia chromosome" that causes chronic myeloid leukemia, and in 2001 the Food and Drug Administration approved the drug imatinib to disable the action of this cancer-causing genetic change.
Many people get on with their lives after traumatic experiences without any psychological suffering. This is because, in spite of all the trauma, they manage to pigeonhole what they have experienced. Although this sense of coherence was first described in the 1970s, measuring it has remained problematic to this day.
SYGNIS AG, the Group which includes Expedeon Holdings, Expedeon, and C.B.S. Scientific Company, today announced the launch of its TruePrime apoptotic cell free DNA amplification kit, under the Expedeon brand.
› Verified 4 days ago
Provider Name | Manshi V Patel |
---|---|
Provider Type | Practitioner - Occupational Therapist In Private Practice |
Provider Identifiers | NPI Number: 1427692565 PECOS PAC ID: 6709219413 Enrollment ID: I20191211001728 |
News Archive
Forthcoming in Physiological and Biochemical Zoology, a fascinating new selection of papers collects leading experimental research in evolution and artificial selection, providing insight into how organisms adapt to changing environmental conditions and fluctuations.
In 1960, scientists described the "Philadelphia chromosome" that causes chronic myeloid leukemia, and in 2001 the Food and Drug Administration approved the drug imatinib to disable the action of this cancer-causing genetic change.
Many people get on with their lives after traumatic experiences without any psychological suffering. This is because, in spite of all the trauma, they manage to pigeonhole what they have experienced. Although this sense of coherence was first described in the 1970s, measuring it has remained problematic to this day.
SYGNIS AG, the Group which includes Expedeon Holdings, Expedeon, and C.B.S. Scientific Company, today announced the launch of its TruePrime apoptotic cell free DNA amplification kit, under the Expedeon brand.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Range Of Motion Physical Therapy, P.a. 4 Cornwall Dr, Suite 220, East Brunswick, NJ 08816-3332 Ph: (732) 257-0900 | Range Of Motion Physical Therapy, P.a. 4 Cornwall Dr, Suite 220, East Brunswick, NJ 08816-3332 Ph: (732) 257-0900 |
News Archive
Forthcoming in Physiological and Biochemical Zoology, a fascinating new selection of papers collects leading experimental research in evolution and artificial selection, providing insight into how organisms adapt to changing environmental conditions and fluctuations.
In 1960, scientists described the "Philadelphia chromosome" that causes chronic myeloid leukemia, and in 2001 the Food and Drug Administration approved the drug imatinib to disable the action of this cancer-causing genetic change.
Many people get on with their lives after traumatic experiences without any psychological suffering. This is because, in spite of all the trauma, they manage to pigeonhole what they have experienced. Although this sense of coherence was first described in the 1970s, measuring it has remained problematic to this day.
SYGNIS AG, the Group which includes Expedeon Holdings, Expedeon, and C.B.S. Scientific Company, today announced the launch of its TruePrime apoptotic cell free DNA amplification kit, under the Expedeon brand.
› Verified 4 days ago
Mrs. Alexandria Mcsweeney, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 15 Kossman St, East Brunswick, NJ 08816 Phone: 732-698-1468 | |
Rehabilitation Services Associates Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3 Tremblay Rd, East Brunswick, NJ 08816 Phone: 732-254-0772 Fax: 732-257-0033 | |
Joanna Suchcicka, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 758 Highway 18, Suite 106, East Brunswick, NJ 08816 Phone: 732-290-0090 Fax: 732-254-2292 | |
Dr. Helena C Zarco, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 180 Tices Ln, East Brunswick, NJ 08816 Phone: 908-705-7570 | |
Lifespan Therapy & Sports Rehab Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 758 Highway 18, Ste 106, East Brunswick, NJ 08816 Phone: 732-254-0090 Fax: 732-254-2292 | |
Erin Ciarrocca, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4 Cornwall Dr Ste 100a, East Brunswick, NJ 08816 Phone: 732-967-1000 |